Testing the external validity of EORTC 30904 comparing overall survival after radical nephrectomy vs nephron sparing surgery in contemporary North American patients with renal cell cancer.

Title : Testing the external validity of EORTC 30904 comparing overall survival after radical nephrectomy vs nephron sparing surgery in contemporary North American patients with renal cell cancer

Source : PubMed
ID : 28972695
Authors : Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C, Abdollah F
Year : 2017
Disease Category : Cancer
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Trial participants vs. eligible patients (by applying eligibility criteria on the patient data) : Yes
Real-world data sources : National Cancer Database (NCDB) patients who meet the criteria
Target Population Data Type Levels : National